- Home
- KURA vs CBLL Comparison
KURA vs CBLL Comparison
Compare KURA & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | CBLL |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 865.4M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | KURA | CBLL |
|---|---|---|
| Price | $8.35 | $19.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $26.88 | $24.67 |
| AVG Volume (30 Days) | ★ 1.4M | 316.2K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $104,029,000.00 | $82,813,000.00 |
| Revenue This Year | $88.72 | $37.44 |
| Revenue Next Year | $68.75 | $27.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.93 |
| 52 Week Low | $5.41 | $10.01 |
| 52 Week High | $12.49 | $26.04 |
Technical Indicators
Market Signals| Indicator | KURA | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 46.39 |
| Support Level | $7.50 | $19.80 |
| Resistance Level | $8.08 | $21.95 |
| Average True Range (ATR) | 0.34 | 1.07 |
| MACD | 0.07 | -0.12 |
| Stochastic Oscillator | 68.99 | 47.89 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.